David G. Dolan
David G. Dolan
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
David G. Dolan has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Alison Nimrod Perkins
Eli Lilly and Company, Indianapolis, IN, USA
1 shared publication - Andreas Häner
F. Hoffmann-La Roche, Basel, Switzerland
1 shared publication - Claudia Sehner
Boehringer Ingelheim Pharma GmbH & Co. KG, Germany
1 shared publication - Erick Nfon
Johnson & Johnson, Beerse, Belgium
1 shared publication - Ester Lovsin Barle
Novartis Pharma AG, Novartis Business Services, Postfach, CH-4002, Basel, Switzerland; Takeda Pharmaceutical Company Limited, Thurgauerstrasse 130, CH-8152, Glattpark (Opfikon), Switzerland
1 shared publication - Eva Zeller
Boehringer Ingelheim, Germany
1 shared publication
Latest Publications
- Open Access
- 19 May 2026
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 170, 106132
Derivation of an occupational exposure limit (OEL) for a potent bispecific protein—Blinatumomab (BLINCYTO®)
- 19 May 2026
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 170, 106132
Open AccessDerivation of an occupational exposure limit (OEL) for a potent bispecific protein—Blinatumomab (BLINCYTO®)
- 31 May 2024
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 151, 105651
Evaluation of the EMA log kow trigger for fish BCF testing based on data for several human pharmaceuticals
- 31 May 2024
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 151, 105651
Evaluation of the EMA log kow trigger for fish BCF testing based on data for several human pharmaceuticals
- 1 August 2020
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 115, 104692
Deriving harmonised permitted daily exposures (PDEs) for paracetamol (acetaminophen) CAS #: 103-90-2
- 1 August 2020
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 115, 104692
Deriving harmonised permitted daily exposures (PDEs) for paracetamol (acetaminophen) CAS #: 103-90-2